Reading Material

For those who are interested in learning more about the issues to be addressed at the conference, the following articles are suggested.

  1. David, Eric, Amit Mehta, Troy Norris, Navjot Singh, and Tony Tramontin. 2010. “New frontiers in pharma R&D investment.” McKinsey Quarterly.
  2. Fernandez, Jose Maria., Roger M. Stein, and Andrew W. Lo. 2012. “Commercializing biomedical research through securitization techniques.” Nature Biotechnology 30: 964-975.
  3. Huggett, Brady. 2012. “Biotech’s wellspring: a survey of the health of the private sector.” Nature Biotechnology 30: 395-400.
  4. Milken Insitute and FasterCures. 2012. “Fixes in Financing: Financial Innovations for Translational Research.” A Financial Innovations Lab Report.
  5. Yang, Walter. 2012. “2011–Big biotechs gorge on debt.” Nature Biotechnology 30: 127.